Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Newcells Biotech

Newcells Biotech
2014 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
1 INVESTORS
Description

Provider of an iPSC technology for drug discovery designed to offer customers with high quality cells. The company's iPSC technology uses pluripotent stem cells, derived from the reprogramming of adult cells into a cell which can reproduce indefinitely and be transformed into almost any other cell type, in drug discovery and development, enabling researchers to research and test new drugs and screen potential drug molecules for efficacy and toxicity.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • Biomedicine West, International Centre for Life
  • Times Square
  • Newcastle upon Tyne NE1 4EP
  • England

+44 0191 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Newcells Biotech’s full profile, request a free trial.

Newcells Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 10-Oct-2016 Completed Startup
1. Seed Round 02-Sep-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Newcells Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Northstar Ventures Venture Capital Minority 000 0000 000000 0

Newcells Biotech Executive Team (3)

Name Title Board
Seat
Contact
Info
Michael Nicholds Board Member & Chief Executive Officer
Lyle Armstrong Ph.D Board Member & Chief Scientific Officer
Majlinda Lako Ph.D Scientific Founder

Newcells Biotech Board Members (2)

Name Representing Role Since Contact
Info
Lyle Armstrong Ph.D Newcells Biotech Board Member & Chief Scientific Officer 000 0000
Michael Nicholds Newcells Biotech Board Member & Chief Executive Officer 000 0000